Asklepion Pharmaceuticals

We are a pediatric rare disease pharmaceutical development company. Asklepion Pharmaceuticals, LLC focuses on the discovery, development, and commercialization of pharmaceutical products for pediatric patients with few therapeutic options, due to the rarity of their conditions. Our pipeline currently focuses on rare and critical diseases in children. We strive to channel science and biotechnology into life-saving therapies, and are dedicated to significantly improving the quality of life for sick children and their families. We commit ourselves to high ethical standards, scientific rigor, consistency, and accessibility, so that we can begin to build a better future for children who need our help. Asklepion Pharmaceuticals is comprised of a small group of professionals based in Baltimore, Maryland. We actively engage in partnerships with universities, pharmaceutical companies, distributors, and financial assistance programs to build a firm foundation for FDA product approval and commercialization.